[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].
Anan K, Tanaka M, Mitsuyama S, Imamura S, Ohno S, Hara S, Oikawa T, Fujii T, Nishimura R, Ishikawa E, Yano H, Taniguchi H, Ohkido M, Ohchi T, Chijiiwa K, Arime I, Shimada K, Inoue H, Tamura K; Kyushu Breast Cancer Study Group (KBC-SG).
Anan K, et al. Among authors: tamura k.
Gan To Kagaku Ryoho. 2012 May;39(5):747-52.
Gan To Kagaku Ryoho. 2012.
PMID: 22584325
Clinical Trial.
Japanese.